Titlebook: Comprehensive lipid testing and management; Lars A. Carlson Book 2011 Springer Healthcare 2011 Cholestrol.Coronary heart disease.Diabetes.

engrave

fatty-acids

,Schlußbetrachtungen und Ausblick,d risk factor HDL-C [15]. Subsequently, there have been further developments in risk prediction. These and the present status of risk prediction in clinical atherosclerosis have recently been reviewed by Wilson [16], including an overview of the major different risk prediction algorithms (Figure 5.1).

圣人

角斗士

GROSS

情感

Lipid testing and prediction of coronary heart diseased risk factor HDL-C [15]. Subsequently, there have been further developments in risk prediction. These and the present status of risk prediction in clinical atherosclerosis have recently been reviewed by Wilson [16], including an overview of the major different risk prediction algorithms (Figure 5.1).

BALK

残暴

Zielsetzung und Fragestellungen, of the risk associated with different lipid factors within a single patient cohort: the Women’s Health Study [20], the Framingham Offspring Study [21], the AMORIS new (second) study [22] and the INTERHEART study [7].

rectocele

Amnesty

pose of lipid testing, diagnosis and lipid profiles as well as the goals of treatment and pharmacological management of lipid levels.The book is divided into two parts, one covering lipid testing and one covering lipid management in the prevention of cardiovascular disease.978-1-907673-03-0978-1-908517-33-3